2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NVOX 2倍做多NVO ETF-Defiance

盘前交易 11-11 08:26:40 EST

10.57

-0.37

-3.38%

盘前10.52

-0.05-0.47%

07:26 EST

最高10.60	最低10.40	成交量9.41万
今开10.55	昨收10.94	日振幅1.83%
总市值3,359万	流通市值3,359万	总股本317.81万
成交额98.87万	换手率2.96%	流通股本317.81万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"2倍做多NVO ETF-Defiance","latestPrice":10.57,"timestamp":1794344400000,"preClose":10.94,"halted":0,"volume":94060,"hourTrading":{"tag":"盘前","latestPrice":10.52,"preClose":10.57,"latestTime":"07:26 EST","volume":400,"amount":4207.3246,"timestamp":1794400008352,"change":-0.05,"changeRate":-0.00473,"amplitude":0.006537},"delay":0,"changeRate":-0.03382084095063979,"floatShares":3178101,"shares":3178101,"eps":0,"marketStatus":"盘前交易","change":-0.37,"latestTime":"11-11 08:26:40 EST","open":10.55,"high":10.6,"low":10.4,"amount":988666.2590200001,"amplitude":0.018282,"askPrice":10.69,"askSize":36500,"bidPrice":9.65,"bidSize":150,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794407400000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":10.57,"sharesOutstanding":4128101,"nav":10.92,"aum":34704862.92,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":10.52,"preClose":10.57,"latestTime":"07:26 EST","volume":400,"amount":4207.3246,"timestamp":1794400008352,"change":-0.05,"changeRate":-0.00473,"amplitude":0.006537},"postHourTrading":{"tag":"盘后","latestPrice":10.3,"preClose":10.57,"latestTime":"19:30 EST","volume":176,"amount":1832.6317,"timestamp":1794357003668,"change":-0.27,"changeRate":-0.025544,"amplitude":0.025544},"volumeRatio":0.3436119806549708,"impliedVol":0.5959,"impliedVolPercentile":0.0522},"requestUrl":"/m/hq/s/NVOX","defaultTab":"news","newsList":[{"id":"2682305102","title":"韩国食品药品安全部周三表示，自本周起，民众可携带最多三个月用量、在境外合法购买的减重药物入境。新规规定，手提行李内最多可","url":"https://stock-news.laohu8.com/highlight/detail?id=2682305102","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682305102?lang=zh_cn&edition=full","pubTime":"2026-11-11 19:15","pubTimestamp":1794395736,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOC","NVOX","NVOH","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682323068","title":"美FDA要求GLP-1类减肥药新增视力损伤风险警告：Wegovy、Zepbound等药物在列","url":"https://stock-news.laohu8.com/highlight/detail?id=2682323068","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682323068?lang=zh_cn&edition=full","pubTime":"2026-11-11 09:27","pubTimestamp":1794360443,"startTime":"0","endTime":"0","summary":"11月11日，美国食品药品监督管理局(FDA)当地时间周一表示，在发现GLP-1类药物可能增加一种罕见眼部疾病的风险后，要求所有GLP-1类药物新增相关安全警告。该疾病可能导致患者突然视力下降，甚至永久性失明。这种眼部疾病名为非动脉炎性前部缺血性视神经病变(NAION)。目前，该疾病较为罕见，且尚未有确凿证据证明其与GLP-1类药物之间存在直接因果关系。FDA表示，已要求所有GLP-1类药物生产商(礼来、诺和诺德)在药品说明书中增加警告，提示使用这些药物可能伴随NAION风险上升。\n\n美股频道更多独家策划、专家专栏，免费查阅>>\n\n            责任编辑：栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2026/11/11092759096572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LABU","XLVI","NVOH","NBDS","IYH","PJP","BK4585","FHLC","PINK","NVOC","BK4588","JDOC","RSPH","CURE","MEDI","NVOX","FXH","TRUH","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682323299","title":"美FDA要求GLP-1类减肥药新增视力损伤风险警告：Wegovy、Zepbound等药物在列","url":"https://stock-news.laohu8.com/highlight/detail?id=2682323299","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682323299?lang=zh_cn&edition=full","pubTime":"2026-11-11 09:26","pubTimestamp":1794360370,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","RSPH","NVOH","FXH","TRUH","BK4585","THNR","LABU","PJP","NVOX","JDOC","IYH","FHLC","XLVI","PINK","NVOC","MEDI","CURE","NBDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682931857","title":"乐普医疗(300003.SZ)子公司MWX205注射液获得药品临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2682931857","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682931857?lang=zh_cn&edition=full","pubTime":"2026-11-10 21:10","pubTimestamp":1794316215,"startTime":"0","endTime":"0","summary":"智通财经APP讯，乐普医疗(300003.SZ)发布公告，公司于今日获悉，公司控股子公司上海民为生物技术有限公司(简称“上海民为生物”)收到国家药品监督管理局核准签发的《药物临床试验批准通知书》(通知书编号：2026LP03439)，由上海民为生物申报的MWX205注射液临床试验申请获得批准。研究名称：一项评估MWX205注射液在混合型血脂异常的成年参与者中的随机、双盲、安慰剂对照、单剂量递增中安全性、耐受性、药代动力学和药效学的I期临床研究。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1521323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0114","BK0188","BK0251","NVOH","BK0201","300003","TBXU","NVOX","BK0042","NVOC","BK0113","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682367354","title":"FDA警示Wegovy、Zepbound等热门减肥药存在失明风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2682367354","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682367354?lang=zh_cn&edition=full","pubTime":"2026-11-10 16:42","pubTimestamp":1794300130,"startTime":"0","endTime":"0","summary":"FDA 表示，目前市面所有 GLP1 药物均已有 NAION 相关病例报告。FDA 称，当前市场上所有已上市 GLP1 制剂，均收到过 NAION 的病例上报。已联系 Wegovy、Ozempic 的生产企业诺和诺德，以及 Mounjaro、Zepbound、Foundayo 的生产商礼来制药，希望获取两家公司的回应。动物实验显示，Wegovy 与 Ozempic 的活性成分司美格鲁肽，以及 Mounjaro 活性成分替尔泊肽，会导致啮齿动物出现甲状腺 C 细胞肿瘤；但目前尚不清楚该类药物是否会在人类身上诱发包括罕见甲状腺癌在内的同类肿瘤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-11-10/doc-iniyfuyw5964610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["NVOX","TRUH","FXH","BK4585","BK4588","NVOC","PINK","NBDS","RSPH","MEDI","THNR","XLVI","FHLC","PJP","CURE","NVOH","IYH","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682033233","title":"美国FDA要求司美格鲁肽、替尔泊肽等GLP-1药物新增眼病风险警告","url":"https://stock-news.laohu8.com/highlight/detail?id=2682033233","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682033233?lang=zh_cn&edition=full","pubTime":"2026-11-10 06:00","pubTimestamp":1794261621,"startTime":"0","endTime":"0","summary":"美国药品监管机构要求Ozempic、Zepbound等热门GLP-1药物在标签警告栏中注明潜在眼部风险，相关药企表示将配合评估，分析师认为市场影响有限。$美国食品$药品监督管理局周一要求所有具有GLP-1受体激动剂活性的药物，在标签\"警告与注意事项\"栏中新增关于非动脉炎性前部缺血性视神经病变潜在风险的相关信息。礼来发言人表示，FDA的药品安全通告适用于所有GLP-1药物，并非针对礼来产品的特定发现，公司正在仔细评估相关更新并将及时回应监管要求。","market":"other","thumbnail":"https://static.tigerbbs.com/f156a54f9e4928ab062a3cdbe13dd440","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f156a54f9e4928ab062a3cdbe13dd440"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3785600","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","RSPH","THNR","BK4588","MEDI","NVOH","NVOC","JDOC","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682293384","title":"膳食补充剂会成为GLP‑1减肥药热潮下的下一大风口吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2682293384","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682293384?lang=zh_cn&edition=full","pubTime":"2026-11-09 23:08","pubTimestamp":1794236880,"startTime":"0","endTime":"0","summary":"Novonesis 首席执行官周一向 表示，膳食补充剂或将成为减肥药浪潮中又一大受益赛道；这家生物解决方案企业正在研究微生物组相关产品，希望可以为服用热门 GLP1 药物的患者提供帮助。Novonesis 研发的微生物组产品不同于普通蛋白质、维生素补剂，该产品对 GLP1 用药人群的潜在益处目前还没有得到证实。该公司人类健康业务第三季度营收同比下滑 8%，主要受北美线下渠道益生菌补充剂需求疲软拖累。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-11-09/doc-iniyehxq6321344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CURE","NVOC","NVOX","PINK","TRUH","NVOH","RSPH","THNR","PJP","IYH","FHLC","XLVI","MEDI","NBDS","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681609158","title":"礼来将在Hims & Hers平台直接销售减重药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2681609158","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681609158?lang=zh_cn&edition=full","pubTime":"2026-11-06 22:52","pubTimestamp":1793976720,"startTime":"0","endTime":"0","summary":"礼来公司周五宣布达成合作协议，授权远程医疗平台 Hims & Hers Health 在其平台直接销售肥胖症药物 Zepbound 与 Foundayo；消息一出，这家远程医疗公司涨幅超 7%。此前，患者若想在 Hims & Hers 平台购买礼来这两款药物，必须跳转至礼来自有自费购药平台 LillyDirect。该协议意味着 Hims & Hers 已经拿下两大 GLP1 龙头药企的正规供货渠道。尤法同时说明，作为合作条件，Hims & Hers 承诺不再售卖礼来肥胖药物的复方制剂以及仿冒产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-11-06/doc-inixvmnq8645927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVOX","NVOC","NVOH","238490.KR","OZEM","BK9067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681867195","title":"Hims & Hers股价上涨2.6%，此前礼来将在该公司平台上销售其减肥药。","url":"https://stock-news.laohu8.com/highlight/detail?id=2681867195","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681867195?lang=zh_cn&edition=full","pubTime":"2026-11-06 22:37","pubTimestamp":1793975871,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FXH","IYH","NVOX","NBDS","TRUH","NVOH","PINK","CURE","MEDI","THNR","RSPH","FHLC","NVOC","XLVI","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681631788","title":"礼来将在Hims & Hers平台上销售其减肥药，Hims & Hers盘前股价上涨7.5%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2681631788","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681631788?lang=zh_cn&edition=full","pubTime":"2026-11-06 19:52","pubTimestamp":1793965965,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOX","NVOC","RSPH","PJP","MEDI","CURE","FXH","TRUH","XLVI","NBDS","IYH","FHLC","NVOH","THNR","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100178380","title":"ETF日报 | 2倍做多AppLovin ETF涨近63%；2倍做多恐慌指数期货ETF涨超61%；三倍做空半导体ETF涨超39%；避险情绪升温","url":"https://stock-news.laohu8.com/highlight/detail?id=1100178380","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100178380?lang=zh_cn&edition=full","pubTime":"2026-11-06 05:16","pubTimestamp":1793913390,"startTime":"0","endTime":"0","summary":"2倍做多APP ETF-Tradr上涨62.42%。该产品两倍做多IT解决方案公司Penguin Solutions，底层公司股价走弱，杠杆机制放大当日跌幅。Penguin Solutions披露将出售其与Cree相关的LED业务并重申长期展望，且获得机构覆盖与合作伙伴关系进展，市场围绕业务调整与前景展开再评估。Tradr 2X Long AXTI Daily ETF下跌45.89%。2倍做多SNDK ETF-Leverage Shares下跌44.31%。大盘指数ETF涨幅Top 5纳指三倍做空ETF上涨19.23%。2倍做多黄金ETF-ProShares上涨1.69%。行业指数ETF涨幅Top 5三倍做空半导体ETF-Direxion Daily上涨38.98%。债券ETF涨幅Top 5iShares New York Muni Bond ETF上涨0.48%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UWM","SGOL","FAZ","JDST","FGDL","COZX","NYF","SPYU","ALA","DXD","03086","DULL","DWAT","BK4561","AXTX","QQQ","RWM","GDXY","PENU","SSO","GDXD","NBIG","DZZ","SHNY","SNDC","SOXL","LITC","SQQQ","VTWO","SNDG","QMAR","LITU","AUAU","UVXY","SMDD","NJAN","NRGZ","NUMI","XITK","VTEB","07568","FSMD","GMUB","HYD","QDEC","FGBXmain","03455","VIXmain","AXTI","SNXX","BK4147","GCmain","GENM","BGLD","GPIQ","NVOH","SNDU","BK4593","QPX","USSX","XW","PSQ","WTID","AXTU","LU2087625088.SGD","GLDM","GLD","GLDW","ONEH","SCHM","USG","APPX","BK4170","APPC","09086","LU0963586101.USD","LU1861220033.SGD","DUST","DDM","URTY","HYD.AU","IAU","USO","HIBS","NBIC","BK4570","QQQX","BTGD","BK4588","SAA","LU2360107168.USD","CNAV","LU2290526834.HKD","BK4585","GDX","AXTC","QQQG","NBIZ","BK7016","ACWV","RGTU","SCHA","TEUP","VIX","NVOC","SVIX","NUGY","SGDJ","03034","09834","CEF","DGP","FDN","RGTC","TQQQ","GDXU","GDMN","GTR","UVIX","UDOW","IGTR","UCO","PALL","VRC","SPXU","SPXT","SPTI","GDXW","YSPY","TPRY","TZA","DGZ","LU1861215975.USD","TNA","DBC","NBIL","02834","AXTQ","GBUG","NAPR","MUB","TWM","07522","IAUI","LU0054578231.USD","RING","LABX","LU0353189680.USD","SPYM","SPYQ","SPXL","NVTX","SMAX","PHYS","DMAX","VOO","JNUG","UYM","MMAX","OVQ","ONTX","SMN","QLD","07266","SDOW","SRTY","TQQY","FTOH","SOXS","SNDQ","512480","SIMX","MMSD","LUMA","NEBX","QID","IVV","BSMM","SCO","BK4007","DOG","NVOX","EUCG","OILD","TMSL","SPXS","OSSL","OUNZ","SPDN","ERY","HIBL","QQQM","GLDI","SH","RGTX","SPUU","FTMA","BSMU","AXTL","RGTZ","BK7084","PTF","AVMU","GBLO","MMIT","ETNG","MYMJ","IGLD","BSMQ","FNGD","DUG.AU","IAUM","DISK","RGYY","IWM","UGL","YGLD","SPYH","DIA","GLL","07261","COWG","NUGT","SGDM","VRTL","SNDK","LAZR",".DJI","GOLY","FCUS","METL","GDXJ","NJUL","SPY","AAAU","LU2063271972.USD","LU2543165471.USD","SKF","BSMT","GLDY","GDX.AU","SDS","LITX","GOAU","BSMV","PTLC","SMN.AU","SVXY","BK4550","NOCT","BAR","PMIO","MVV","KGLD","OPTZ","LITZ","LITG","NVTC","DUG","SKF.AU","UPRO","FTCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192510871","title":"港股存储、光通信、PCB概念股重挫，南方最多两倍做多海力士跌超15%、罗博特科跌超10%、建滔积层板跌超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192510871","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192510871?lang=zh_cn&edition=full","pubTime":"2026-11-05 09:35","pubTimestamp":1793842528,"startTime":"0","endTime":"0","summary":"11月5日，港股存储概念股走低，南方最多两倍做多海力士跌超15%，$南方两倍做多三星电子(07747)$跌近12%，$澜起科技(06809)$跌超6%，$兆易创新(03986)$跌超5%；光通信概念股普跌，罗伯特科跌超10%，$中际旭创(03308)$、$长飞光纤光缆(06869)$跌超8%，$海光芯正(01191)$、$剑桥科技(06166)$跌超6%；PCB概念股普跌，$建滔积层板(01888)$、$广合科技(01989)$跌超9%，$东山精密(02384)$跌超8%，建滔集团跌超7%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023057109.AUD","SPXS","LU0708995583.HKD","LU1282649141.HKD","SKHX","07747","01888","LU1328277881.USD","LITZ","PCB","LU2039709279.SGD","BK1209","RGTC","SSO","BK1122","LU0823397285.USD","LU1956131251.USD","RGYY","BK1537","SKUU","SKHYV","BK4588","NBIC","LU0501845795.SGD","RGTZ","LU0052750758.USD","RAM","BK1240","LUMA","LU0314109678.HKD","IVV","SDS","LU2187417386.USD","LU1152091754.HKD","LU1282649810.SGD","ONTX","NEBX","LU1655091616.SGD","SPXU","LITX","ALA","NVTX","LU0320764599.SGD","COZX","LU2351347302.SGD","HK0000352291.HKD","SKHZ","SPYH","03308","SPUU","LU0588546209.SGD","LU0384037296.USD","BK4007","BK1170","BK4585","LU1808992512.USD","LU0072913022.USD","SKHA","LU0359202008.SGD","SIXG","BK1523","BK4211","XW","NVOH","LU0211977185.USD","NBIG","KCAI","BK1149","SKHL","LU1255011170.USD","LU0274383008.USD","SKHU","SMAX","OSSL","BK1163","06869","07709","LYTE","BK1533","VRC","EMXC","NVTC","01989","LU0823413587.USD","SIMX","000660.KR","LU1152091168.USD","DMAX","LU2929501877.USD","BK1506","SPY","SKHY","HYNX","FPA","FOTO","LU1008478684.HKD","LU0823413660.USD","LU0307460666.USD","MCHS","SKHQ","SPYU","BK1147","LU1813983027.USD","LU0488056044.USD","LU0880133367.SGD","ETNG","06809","SG9999004220.SGD","VRTL","LU0359201612.USD","01191","RGTU","LABX","VOO","SKHN","DRAL","LU1807302812.USD","LU0823397103.USD","06166","UPRO","MMAX","HIBL","LITU","LU2543165471.USD","LU0067412154.USD","SH","LU1993786604.SGD","RAMZ","LU1211504680.USD","NBIZ","SPXL","VXUS","LU1282649067.USD","BK1249","LITC","HK0000352382.USD","DRAM","91210","NVOX","NBIL","YSPY","BK4141","LU1960683339.HKD","MVV","LU0648948544.HKD","SAA","LU0359201885.HKD","LITG","SG9999006597.SGD","SPDN","SPYM","91530","02384","SK","SPYQ","SKDD","NVOC","03986","RGTX","TEUP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680032661","title":"诺和诺德（NVO）涨3.11% Q3利润47亿美元 同比大增27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680032661","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680032661?lang=zh_cn&edition=full","pubTime":"2026-11-04 18:42","pubTimestamp":1793788946,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德 盘前股价上扬，最新涨3.11%，报41.44美元。消息面上，诺和诺德11月4日公布2026年前三季度财报。第三季度销售额791.95亿丹麦克朗，同比增长6%，高于分析师预期的732.2亿克朗；调整后营业利润317.20亿克朗，固定汇率口径同比大增27%，高于预期的283.9亿克朗。调整后净利润256.02亿克朗，同比增长12%；调整后摊薄每股收益5.79克朗。此外，调整后营业利润27%的高增速部分受益于上年同期90亿克朗全球转型成本带来的低基数。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/MDYxNTA2ZjhkOWVmNGY4NWFiMzk3MGE5NjBhODhjODE3MzYyMzc3Njg0MzY=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MDYxNTA2ZjhkOWVmNGY4NWFiMzk3MGE5NjBhODhjODE3MzYyMzc3Njg0MzY=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"307969","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","OZEM","BK4588","NVOC","NVOX","PPH","LU1093756168.USD","LU1093756325.SGD","THNR","IE00BZ1G4Q59.USD","BK4599","LU0154236417.USD","NVOH","NVO","BK4532","BK4007","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107684597","title":"诺和诺德再次上调2026年业绩展望，Wegovy减肥药片销售超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1107684597","media":"老虎资讯综合","labels":["EditorSelect","movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107684597?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:16","pubTimestamp":1793783769,"startTime":"0","endTime":"0","summary":"减肥药Wegovy的生产商诺和诺德（Novo Nordisk）周三公布，第三季度调整后营业利润高于市场预期，并上调了2026年全年利润和销售额预期。","market":"us","thumbnail":"https://community-static.tradeup.com/news/02a66cb4d7a54efc5afa3a7697ecf06f","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/02a66cb4d7a54efc5afa3a7697ecf06f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"EditorSelect,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOC","NVOH","NVOX","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680676087","title":"诺和诺德首席执行官：Wegovy 减肥药在美国的销售额在第三季度增长了 20%；“我认为，增长曲线已经趋于平缓，这已经不","url":"https://stock-news.laohu8.com/highlight/detail?id=2680676087","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680676087?lang=zh_cn&edition=full","pubTime":"2026-11-04 15:25","pubTimestamp":1793777129,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CURE","FHLC","MEDI","XLVI","THNR","NVOC","NVOX","PINK","PJP","TRUH","NBDS","NVOH","IYH","FXH","RSPH","BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680024084","title":"诺和诺德上调全年业绩指引，Wegovy减肥药片销量表现亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2680024084","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680024084?lang=zh_cn&edition=full","pubTime":"2026-11-04 14:59","pubTimestamp":1793775540,"startTime":"0","endTime":"0","summary":"丹麦制药公司诺和诺德周三早些时候公布的季度业绩超出市场预期，主要得益于其Wegovy口服减肥药片销量远超预期。在经历了动荡的一年、市场表现落后于竞争对手礼来之后，诺和诺德正努力重振业务增长势头。该公司更新了全年业绩指引，预计按固定汇率计算，调整后营收和营业利润增速均为-2%至2%。诺和诺德此前已于8月上调过全年业绩预期。第三季度，诺和诺德实现销售额792亿丹麦克朗，同比增长4%，高于FactSet调查分析师预期的736亿丹麦克朗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-11-04/doc-inixqaau9424361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVOX","PJP","MEDI","FHLC","IYH","TRUH","CURE","NVOC","BGIA","FXH","PINK","RSPH","NVOH","XLVI","NBDS","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124903521","title":"诺和诺德Q3业绩超预期，再次上调全年业绩指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1124903521","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124903521?lang=zh_cn&edition=full","pubTime":"2026-11-04 14:44","pubTimestamp":1793774689,"startTime":"0","endTime":"0","summary":"11月4日，诺和诺德美股夜盘涨超3%，第三季度调整后销售额 792亿丹麦克朗，市场预期 735.5亿丹麦克朗。第三季度调整后息税前利润 317.2亿丹麦克朗，市场预期 287.1亿丹麦克朗。第三季度调整后Wegovy口服药销售额 53.9亿丹麦克朗，市场预期 46.4亿丹麦克朗。预计全年调整后销售额按固定汇率计算增长-2%至+2%，市场预期增长-2.35%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德Q3业绩超预期，再次上调全年业绩指引","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","NVOC","NVO","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680084600","title":"诺和诺德：第三季度美国Wegovy减肥药处方总量达到360万张，自推出以来已超过800万张。","url":"https://stock-news.laohu8.com/highlight/detail?id=2680084600","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680084600?lang=zh_cn&edition=full","pubTime":"2026-11-04 14:43","pubTimestamp":1793774608,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDI","NVOC","THNR","FXH","PINK","FHLC","NBDS","IYH","CURE","XLVI","RSPH","NVOH","NVOX","PJP","BGIA","TRUH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188739521","title":"ETF日报 | 2倍做多Aehr Test Systems ETF涨近53%；2倍做多Riot Platforms ETF涨超37%；3倍做多半导体ETF涨超7%；加密与半导体杠杆领涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1188739521","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188739521?lang=zh_cn&edition=full","pubTime":"2026-11-04 05:16","pubTimestamp":1793740595,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5Leverage Shares 2X Long AEHR Daily ETF上涨52.80%。该产品两倍做多半导体测试设备公司Aehr Test Systems，底层公司股价走强，杠杆机制放大当日涨幅。Aehr Test Systems在公布季度业绩后股价走强，机构给予积极评价，并披露获得面向AI芯片测试的新增订单。美股ETF跌幅Top5Tradr 2X Short IREN Daily ETF下跌22.63%。2倍做多SHOP ETF-Direxion下跌16.86%。大盘指数ETF涨幅Top 5韩国ETF-iShares MSCI上涨2.27%。债券ETF涨幅Top 5iShares Convertible Bond ETF上涨0.74%。First Trust SSI Strategic Convertible Securities ETF上涨0.71%。VanEck Preferred Securities ex Financials ETF上涨0.55%。SPDR Blackstone Senior Loan ETF上涨0.35%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DZZ","NVTX","KORU","ICVT","UCO","LU1548497426.USD","SPXS","UPRO","DUG","RGTX","IAUM","BK4551","AEHR","VRC","LU0390134368.USD","SGOL","PFXF","RGYY","QQQX","QDEC","DIA","BK4007","LU1429558221.USD","FGDL","SMH","09086","CRC","ETNG","FAZ","DGP","NJAN","BK7084","OSSL","CRWU","MNRS","BKCH","LITZ","LU0081259029.USD","RIOX","SPDN","DDM","FWD","BK4609","SPUU","BK4213","SMN.AU","CRWG","LU2357305700.SGD",".DJI","NBIC","SMHU","LU1861558580.USD","IVV","09834","DGZ","LITX","BK4535","CRWV","SHPD","SPYQ","GLL","TAN","ZSL","SIVR","02834","BEX","FCVT","VOO","GLDY","NBIZ","BNDW","OVQ","BK4116","APLX","LU2063271972.USD","NBDS","GLDM","CIFG","RTYY","07266","SSG","IAU","159582","LU1435385759.SGD","YMmain","NVOX","BK4600","AEHG","BK4563","DUG.AU","USG","03455","LITC","LU0266013472.USD","SPYM","LAZR","SPY","VGT","QLD","ONTX","BK7016","BK4528","LU0823421333.USD","YGLD","GLD","GPIQ","BK4566","SIMX","NJUL","FTXL","RGTU","RIOT","SHNY","UGL","CHPS","LU1804176565.USD","DXD","NVOH","NOCT","DUST","BK4524","CWC","TEKX","RGTC","CORD","ALA","LU1691799644.USD","LU1720051108.HKD","FDIG","BK4516","LU1623119135.USD","TQQQ","NVOC","SRLN","BGLD","QQQ","NVTC","SMN","LITU","NBIG","PSI","NBIL","DAPP","LU2326559502.SGD","USD","APLZ","AAAU","LITG","SHPU","03034","TQQY","MVV","NAPR","PSQ","SOXQ","TEUP","CWB","DBC","DOG","COZX","LU0266512127.USD","SSO","XSD","BEC","BK4593","07261","CWVX","IREG","QMAR","BLOX","SOXS","CIFU","VRTL","SMAX","512480","BK4147","BK4550","SH","BK4548","IREZ","NEBX","SAA","SLV","BK4608","LU1861559042.SGD","SPYU","IREX","SPYH","BK7104","BK4023","IGLD","BEZ","DULL","BAR","BK4585","MMAX","APLD","SDS","IAUI","DMAX","LU1712237335.SGD","GDXY","LU1720051017.SGD","BK4595","IRE","NRGZ","07568","MQQQ","CIFC","SQQQ","SMHX","UDOW","CHPY","GDXW","LU2265009873.SGD","HIBL","YSPY","XW","FDN","CRWX","SHOP","SOXY","SPXL","LU0456854461.SGD","TECY","BK4588","LFGY","SOXL","RGTZ","CWII","LU0823421416.USD","OUNZ","NUGT","IBLC","BK4532","KGLD","SPXU","QQQM","SOXX","EWY","LABX","BEZ.AU","EIS","IREC","QID","07522","SDOW","AGQ","03086","BEG","BK4613"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1174388142","title":"港股存储、光通信概念股跌幅居前，纳真科技跌超10%、南方最多两倍做多海力士跌超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174388142","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174388142?lang=zh_cn&edition=full","pubTime":"2026-11-03 09:41","pubTimestamp":1793670116,"startTime":"0","endTime":"0","summary":"11月3日，港股存储概念股跌幅居前，南方最多两倍做多海力士跌超8%，$南方两倍做多三星电子(07747)$跌超6%，$澜起科技(06809)$跌近6%，$兆易创新(03986)$跌超3%；光通信概念股普跌，$纳真科技(09856)$跌超10%，罗伯特科跌超7%，$剑桥科技(06166)$跌超5%，$中际旭创(03308)$、$海光芯正(01191)$跌超4%.","market":"us","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07747","LU2543165471.USD","LU0823397103.USD","BK4588","LU1960683339.HKD","SKHYV","RGTC","LU0067412154.USD","LUMA","RAM","LU0880133367.SGD","91210","LU1655091616.SGD","DMAX","NVTX","LU1008478684.HKD","BK1249","NBIC","TEUP","UPRO","BK1533","MMAX","SDS","SPXU","LU0359201885.HKD","NVTC","SPYM","03308","FOTO","LU1023057109.AUD","SKHZ","ONTX","LU0823397285.USD","KCAI","LU1993786604.SGD","BK4141","HYNX","BK1149","06809","SKHU","IVV","LU1956131251.USD","RGTU","RGYY","SPYH","ALA","NEBX","LU1807302812.USD","LITX","01191","NBIG","NBIL","OSSL","LU0359201612.USD","BK1240","ETNG","DRAM","LU2039709279.SGD","LU0052750758.USD","BK1122","LU0823413587.USD","SPUU","LYTE","VRTL","SMAX","EMXC","LU1255011170.USD","SIXG","SPYQ","LITU","BK1537","RAMZ","NVOH","SAA","VOO","SKHA","MVV","LITC","NVOX","HIBL","SH","LITG","03986","SKHQ","VXUS","VRC","07709","SIMX","LU0823413660.USD","XW","LU0501845795.SGD","000660.KR","BK1170","91530","LU1152091168.USD","SKDD","LU1328277881.USD","BK4007","SPXL","DRAL","RGTX","LU0314109678.HKD","LABX","NBIZ","LU1152091754.HKD","LU0359202008.SGD","SKHY","06166","BK4585","LU1813983027.USD","COZX","SSO","LU0320764599.SGD","RGTZ","SPXS","SK","SKHX","SPDN","SKUU","YSPY","SPY","LU0072913022.USD","SKHN","BK1163","SKHL","09856","NVOC","BK1147","LITZ","SPYU","LU0708995583.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0183},{"period":"1month","weight":0.0897},{"period":"3month","weight":-0.268},{"period":"6month","weight":-0.3058},{"period":"1year","weight":-0.4354},{"period":"ytd","weight":-0.5171}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":-0.0368},{"period":"3month","weight":-0.0292},{"period":"6month","weight":0.0023},{"period":"1year","weight":0.1005},{"period":"ytd","weight":0.0997}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"ARCA","name":"2倍做多NVO ETF-Defiance","nameEN":"Defiance Daily Target 2X Long NVO ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供2倍做多NVO ETF-Defiance(NVOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"2倍做多NVO ETF-Defiance,NVOX,2倍做多NVO ETF-Defiance股票,2倍做多NVO ETF-Defiance股票老虎,2倍做多NVO ETF-Defiance股票老虎国际,2倍做多NVO ETF-Defiance行情,2倍做多NVO ETF-Defiance股票行情,2倍做多NVO ETF-Defiance股价,2倍做多NVO ETF-Defiance股市,2倍做多NVO ETF-Defiance股票价格,2倍做多NVO ETF-Defiance股票交易,2倍做多NVO ETF-Defiance股票购买,2倍做多NVO ETF-Defiance股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供2倍做多NVO ETF-Defiance(NVOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}